Literature DB >> 7576965

Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s.

H J Terpe1, H Christiansen, M Gonzalez, F Berthold, F Lampert.   

Abstract

Cell-cell and cell-extracellular matrix interactions mediated by cell adhesion molecules (for example CD44) play an important role in the cascade of metastasis and the progression of human malignant tumours. The most important aim of this review was, on the basis of our results and the literature, to show the correlation between the expression of CD44s and differentiation and prognosis of neuroblastoma. Surprisingly and in contrast to most other malignant tumours, neuroblastomas exhibited an inverse correlation between CD44s expression and tumour progression. It can be stated that CD44s is a prognostic marker in neuroblastoma which correlates significantly with the grade of tumour cell differentiation, but not with clinical stage. Moreover, there exists a statistically significant correlation between MYCN oncogene amplification and the lack of CD44s expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576965     DOI: 10.1016/0959-8049(95)00061-m

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Relationship between expression of CD44v6 and nm23-H1 and tumor invasion and metastasis in hepatocellular carcinoma.

Authors:  Cheng-Zhi Xiao; Yi-Min Dai; Hong-Yu Yu; Jian-Jun Wang; Can-Rong Ni
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

Review 2.  Targeting focal adhesion kinase in neuroblastoma.

Authors:  Lauren Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

3.  Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?

Authors:  G Humphrey; D L Hazel; K MacLennan; I Lewis
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.

Authors:  Imane Tabyaoui; Nadia Tahiri-Jouti; Zineb Serhier; Mohamed Bennani-Othmani; Hicham Sibai; Mohamed Itri; Said Benchekroun; Soumaya Zamiati
Journal:  Diagn Pathol       Date:  2013-02-27       Impact factor: 2.644

5.  Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.

Authors:  Christiane Matuschek; Marcus Lehnhardt; Peter Arne Gerber; Christopher Poremba; Jackson Hamilton; Guido Lammering; Klaus Orth; Wilfried Budach; Hans Bojar; Edwin Bölke; Matthias Peiper
Journal:  Eur J Med Res       Date:  2014-02-03       Impact factor: 2.175

6.  PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS.

Authors:  Josip Mihić; Krešimir Rotim; Majda Vučić; Ida Hude Dragičević; Marta Borić; Liborija Lugović-Mihić
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.932

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.